Comparing new treatments for idiopathic pulmonary fibrosis--a network meta-analysis.

Thumbnail
Name:
ComparingNewTreatments.pdf
Size:
588.3Kb
Format:
PDF
Download
Authors
Loveman, Emma
Copley, Vicky R
Scott, David A
Colquitt, Jill L
Clegg, Andrew J
O'Reilly, Katherine M A
Affiliation
1Effective Evidence LLP/Southampton Health Technology Assessments Centre (SHTAC), University of Southampton, 1st Floor Epsilon House, Enterprise Road, Southampton SO16 7NS, UK. 2SHTAC, University of Southampton, 1st Floor Epsilon House, Enterprise Road, Southampton SO16 7NS, UK. 3ICON Health Economics, Seacourt Tower, West Way, Oxford OX2 0JJ, UK. 4Mater Misericordiae University Hospital, Dublin, Ireland.
Issue Date
2015
Local subject classification
LUNG DISEASE
PULMONARY FIBROSIS

Metadata
Show full item record
Citation
Comparing new treatments for idiopathic pulmonary fibrosis--a network meta-analysis. 2015, 15:37 BMC Pulm Med
Publisher
BioMed Central
Journal
BMC pulmonary medicine
URI
http://hdl.handle.net/10147/559143
DOI
10.1186/s12890-015-0034-y
PubMed ID
25927225
Abstract
The treatment landscape for idiopathic pulmonary fibrosis, a devastating lung disease, is changing. To investigate the effectiveness of treatments for idiopathic pulmonary fibrosis we undertook a systematic review, network meta-analysis and indirect comparison.
Item Type
Article
Language
en
ISSN
1471-2466
Sponsors
Funder: This research was funded from internal funds from the Southampton Health Technology Assessments Centre (SHTAC) at the University of Southampton, UK. We are grateful to Karen Welch, Information Specialist, SHTAC, University of Southampton, for generating and running the literature searches.
Collections